Marc Scheineson was a featured speaker during the session "Setting the Stage: Public Policy Impacting ENT Innovation" at this conference sponsored by the International Business Forum and hosted in Alston & Bird's Washington, D.C. office. Marc covered the following topics during the session.
- Update on Current Legislation
- Status of Draft Guidance Reworking 510(k) Program
- Increasing Clinical and Other Performance Data Requirements
- Special and Abbreviated 510(k) Submissions
- Impact and Opportunities for ENT Devices
ENT is an exploding area of innovation being driven by unmet clinical needs. Entrepreneurs and physicians are developing surgical technologies and devices that will impact the huge patient populations who suffer from ear, nose and throat disorders globally. Taking place in Washington, D.C., the 3rd Annual ENT Innovation Summit united an intimate group of corporate executives, investors, entrepreneurs and physicians with regulatory and reimbursement experts who addressed commercialization as it relates to overcoming reimbursement and regulatory challenges.
September 11, 2012
12:30 .p.m - 6:30 p.m.
Alston & Bird LLP / Washington, D.C.